RELX's Quality and Safety Lab in Shenzhen Accredited by CNAS

Aug.03.2022
RELX's Quality and Safety Lab in Shenzhen Accredited by CNAS
RELX's Shenzhen quality safety lab gains CNAS certification, ensuring global recognition of its testing reports.

On August 2nd, a Blue Whale Finance journalist learned from RELX Yueke (Fogcore Technology) that its quality and safety laboratory in Shenzhen has received recognition from CNAS (China National Accreditation Board for Laboratories).


According to the information provided, CNAS (China National Accreditation Service For Conformity Assessment) is the English abbreviation for the China National Accreditation Committee for Conformity Assessment. Laboratories accredited by CNAS can issue testing reports that are recognized by more than 100 countries worldwide.


As per reports, the Yooz Quality and Safety Laboratory, mentioned earlier, was established in 2021 and covers an area of 450 square meters, serving as a key support component of the Yooz quality system. The laboratory focuses on testing the physical and electrical properties of products and is the second laboratory accredited by CNAS (China National Accreditation Service) within the company, Fogcore Technology. Yooz's first accredited laboratory, dedicated to testing e-liquid, was certified in August 2020, making it the first e-cigarette brand company to receive CNAS accreditation.


In fact, in daily use, electronic cigarettes in the hands of consumers are inevitably subjected to shocks and impacts, as well as challenges from wind, heat, and cold, with their durability and safety directly affecting the user experience. Therefore, in order to pursue top-quality products, YOOZ, in terms of quality and safety testing, has set up multiple tests including friction, drop, and high temperature in its quality safety laboratory. "At present, we have the ability to carry out testing in accordance with national standards," said Yang Yong, head of the YOOZ Quality Compliance Center. "In addition, we have also improved our testing standards by starting from many invisible details.


For example, YUEKE has an exclusively patented system for assessing suction noise, which helps quality engineers monitor the decibel levels of the sounds emitted during product use in real-time to reduce noise levels to the greatest extent possible and achieve "no disturbance" in terms of hearing. Meanwhile, the company also offers optional testing for cosmetics endurance. Engineers apply skincare products to atomizer rods and observe whether the product's appearance changes in high-temperature, high-humidity environments. This process can test the anti-corrosion abilities of different atomizer rods and identify the most durable products for users.


To address the widely-concerned issue of oil leakage, engineers conducted laboratory experiments simulating high-altitude pressures exceeding 3000 meters above sea level, testing atomized bombs. The tested products greatly mitigate oil leakage caused by changes in pressure.


In March of this year, national standards for electronic cigarettes as well as regulations for their management were issued, marking a move towards the legalization and standardization of the electronic cigarette industry. Yang Yong stated that Yooz will take on its quality responsibilities and strive for the highest quality, creating products that have a pure flavor.


It has been reported that YUEKE, since its inception, has invested a total of 800 million yuan in research and development, creating a matrix of eight large laboratories. In addition to the quality and safety laboratory, there are also innovation laboratories, chemical laboratories, life science laboratories, aerosol laboratories, atomization innovation laboratories, new material laboratories, sensory analysis laboratories, and after-sales testing centers. The quality system covers the entire user experience process.


According to Yang Yong, chemical laboratories can analyze the chemical components of aerosols and sprays, while life science laboratories are responsible for safety testing at the cellular and animal levels. By conducting multiple layers of testing, we ensure that the quality and safety of our products are implemented in every detail.


According to reports, the Yueke Chemical Laboratory tests 19 categories of 140 substances and 12 categories of 102 substances for aerosols. The Life Science Laboratory is capable of conducting six tests, such as cell toxicity, to further confirm product safety.


According to reports, Fogtech has recently been awarded the "License for Tobacco Monopoly Production Enterprise (Electronic Cigarette Product Production Enterprise)". Currently, the company is intensively developing new products that meet national standards, and some products have passed technical evaluations. In its statement, Fogtech said it will continue to aim for a perfect user experience and provide high-quality and reassuring products.


This article contains excerpts or reprints from third-party sources, whose copyright belongs to the original media and author. If there is any infringement, please contact us to delete it. Any organization or individual wishing to reprint must contact the author and refrain from reprinting directly.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Trump Picks White House Health Policy Aide Heidi Overton to Lead FDA, Pending Senate Confirmation
Trump Picks White House Health Policy Aide Heidi Overton to Lead FDA, Pending Senate Confirmation
U.S. President Donald Trump has chosen White House health policy aide Heidi Overton to lead the Food and Drug Administration, Bloomberg reported, citing a person familiar with the matter. Overton currently works on health policy at the White House and previously held a senior role at the America First Policy Institute. If confirmed by the Senate, she would take over an FDA that has experienced months of senior-level turnover. The agency regulates products representing roughly one-fifth of U.S. consumer spending, including e-cigarettes, drugs, vaccines and much of the food supply.
News
Aug.19
Indiana’s Foreign-Made Vape Ban Takes Effect, Forcing Brands and Retailers to Adjust Supply Chains
Indiana’s Foreign-Made Vape Ban Takes Effect, Forcing Brands and Retailers to Adjust Supply Chains
A new Indiana law restricting the sale of foreign-made vape products has taken effect, requiring retailers to adjust inventory and sourcing practices. According to The Sun, WDRB and other reports, some local vape shops are reviewing product origins and supplier information to comply with the new requirements. The measure represents a broader shift in U.S. vape regulation, with oversight expanding beyond product authorization and sales rules toward manufacturing origin and supply-chain management.
Jul.24
U.S. FDA: Youth E-Cigarette Prevention Campaign Prevented About 444,000 Initiations and Reduced Illegal Vape Sales
U.S. FDA: Youth E-Cigarette Prevention Campaign Prevented About 444,000 Initiations and Reduced Illegal Vape Sales
The U.S. Food and Drug Administration (FDA) said its youth e-cigarette prevention campaign, “The Real Cost,” prevented about 444,000 U.S. youth from starting e-cigarette use between 2023 and 2024 and blocked more than $42 million in unauthorized e-cigarette sales that would have been used by youth.
Market
Jun.25
Australia’s Daily Smoking Rate Falls to Record Low of 5.8% as Nicotine Use Patterns Shift
Australia’s Daily Smoking Rate Falls to Record Low of 5.8% as Nicotine Use Patterns Shift
According to the Australian Institute of Health and Welfare’s National Drug Strategy Household Survey, daily smoking among Australians aged 18 and over fell to a record low of 5.8% in 2025. Health Minister Mark Butler said Australia now has around 500,000 fewer daily smokers than three years ago and credited the government’s vaping reforms as part of broader progress. Among people aged 14 and over, daily smoking declined from 8.3% in 2022-23 to 5.6% in 2025. Daily vaping rates stabilised at 3.6%, while the government also moved to further restrict access to nicotine pouches through unapproved therapeutic import pathways.
Jul.21
China Tobacco Regulator Deputy Head Visits Laos as Both Sides Strengthen Cooperation on Illegal Tobacco Trade
China Tobacco Regulator Deputy Head Visits Laos as Both Sides Strengthen Cooperation on Illegal Tobacco Trade
China’s official Xinhua News Agency reported that Liu Sanjiang, deputy head and Party group member of China’s tobacco regulator, led a delegation to Laos from July 31 to Aug. 2, 2026, for discussions with Lao authorities on combating cross-border illegal tobacco trade. The two sides discussed areas including law enforcement cooperation, information sharing and efforts to address tobacco-related illegal activities such as counterfeiting and smuggling. The visit highlights cooperation between Chinese and Lao authorities on illicit tobacco control.
News
Aug.05
Putin Signs Russia’s Tobacco and Nicotine Product Licensing Law, Banning Unlicensed Sales From 2027
Putin Signs Russia’s Tobacco and Nicotine Product Licensing Law, Banning Unlicensed Sales From 2027
Russian President Vladimir Putin has signed a law introducing mandatory licensing for wholesale and retail trade in tobacco and nicotine-containing products, with the system taking effect on October 1, 2026, and unlicensed operations banned from March 1, 2027, while vape and e-liquid retail may also face uncertainty from temporary regional sales-ban powers.
Jul.01